Abstract: A transparent wood comprising at least one polymer and a wood substrate comprising more than 15% lignin, measured as Klason lignin, and having an optical transmittance of at least 60%, as well as a method for its preparation.

Abstract: The present invention relates to a lignin-containing cellulose nanofiber characterized in that (a) the said lignin-containing cellulose nanofiber has a content of carboxyl group in a range of 0.2-1.5 mmol/g, (b) the said lignin-containing cellulose nanofiber has Zeta potential in a range of ?100 to ?35 mV, and (c) the said lignin-containing cellulose nanofiber has an average diameter in a range of 3-30 nm. In addition, the present invention further relates to a paper and a film comprising the said lignin-containing cellulose nanofiber. The present invention also relates to a process for preparing a lignin-containing cellulose nanofiber comprising steps of (i) treating a lignin-containing cellulosic material with an organic solvent, (ii) treating the cellulosic material treated from the step (i) with derivative of N-oxy radical compound and hypochlorite compound, and (iii) mechanical treating the cellulosic material treated from the step (ii).

Abstract: A transparent wood comprising at least one polymer and a wood substrate comprising more than 15% lignin, measured as Klason lignin, and having an optical transmittance of at least 60%, as well as a method for its preparation.

Abstract: The present invention relates to new classes of biocompatible polymers comprising at least one repeating unit derived from a compound of Formula (I) as defined in the claims and specification. These polymers may be biodegradable and bioresorble, and, while not limited thereto, may be adapted for radio-opacity and are useful for medical device applications and controlled release therapeutic formulations. Therefore, methods for preparing these polymers and medical devices prepared therefrom are also encompassed by this disclosure.

Abstract: The invention relates to novel monomers of Formula (I) useful for preparation of phase-separated biocompatible polymers or polymer compositions. These polymers or polymer compositions may be bioresorbable and/or biodegradable and have desirable mechanical properties, such as fracture and/or fatigue toughness, which have not been a primary design criteria for such polymers previously. The polymers or polymer compositions are useful in a variety of medical applications, such as in the fabrication of medical devices. Therefore, methods for preparing these polymers or polymer compositions and medical devices are also encompassed by this disclosure.

Abstract: This invention discloses biocompatible polymers prepared from monomers (IV), and (IVa), or derivatives thereof, for which the variables are described in the claims and specification. These polymers may be bioresorbable and thus useful for manufacture of medical devices. Therefore, methods for preparing these polymers and medical devices prepared therefrom are also encompassed by this disclosure.

Abstract: This invention discloses biocompatible polymers prepared from monomers (IV), and (IVa), or derivatives thereof, for which the variables are described in the claims and specification. These polymers may be bioresorbable and thus useful for manufacture of medical devices. Therefore, methods for preparing these polymers and medical devices prepared therefrom are also encompassed by this disclosure.

Abstract: The invention relates to novel monomers of Formula (I) useful for preparation of phase-separated biocompatible polymers or polymer compositions. These polymers or polymer compositions may be bioresorbable and/or biodegradable and have desirable mechanical properties, such as fracture and/or fatigue toughness, which have not been a primary design criteria for such polymers previously. The polymers or polymer compositions are useful in a variety of medical applications, such as in the fabrication of medical devices. Therefore, methods for preparing these polymers or polymer compositions and medical devices are also encompassed by this disclosure.

Abstract: The present invention relates to new classes of biocompatible polymers comprising at least one repeating unit derived from a compound of Formula (I) as defined in the claims and specification. These polymers may be biodegradable and bioresorble, and, while not limited thereto, may be adapted for radio-opacity and are useful for medical device applications and controlled release therapeutic formulations. Therefore, methods for preparing these polymers and medical devices prepared therefrom are also encompassed by this disclosure.